Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.4 now appears, replacing the previous v3.5.3. The update denotes a minor version bump to the page and its linked documents.
    Difference
    0.1%
    Check dated 2026-05-16T09:19:51.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an internal site release rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T17:14:04.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; previous revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T14:11:14.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added a related term for head and neck squamous cell carcinoma and a new Resources link to the Genetic and Rare Diseases Information Center on the study page.
    Difference
    0.2%
    Check dated 2026-04-03T06:07:41.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed. This update appears to be a maintenance version change without altering study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-20T00:17:32.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    The page now shows revision v3.4.3 replacing the previous v3.4.2. This appears to be a system update that does not affect study content or functionality.
    Difference
    0.1%
    Check dated 2026-03-12T21:29:10.000Z thumbnail image

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.